This observation and recent findings showing significant EGFR copy-number amplification in primary FA HNSCC cells22 strongly suggest that the panErbB CAR-T cells generated in this study should efficiently target HNSCCs in non-FA as well as in patients with FA. Here, EGFR is linked to head and neck squamous cell carcinoma.